+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Medical Marijuana Market by Application and Geography - Forecast and Analysis 2020-2024 - Product Image

Medical Marijuana Market by Application and Geography - Forecast and Analysis 2020-2024

  • ID: 4876566
  • Report
  • November 2019
  • Region: Global
  • 136 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Aphria Inc.
  • Aurora Cannabis Inc.
  • Cannabis Sativa Inc.
  • Canopy Growth Corp.
  • Cronos Group Inc.
  • GW Pharmaceuticals Plc
  • MORE
Global Medical Marijuana Market: About this market
The medical marijuana market analysis considers sales from chronic pain, nausea, and other applications. Our study also finds the sales of medical marijuana in APAC, Europe, MEA, North America, and South America. In 2019, the chronic pain segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the high prevalence of chronic pain among adults in the US will play a significant role in the chronic pain segment to maintain its market position. Also, our global medical marijuana market report looks at factors such as the rising number of product launches, an increasing number of medical marijuana dispensaries, and plans to increase production and availability of medical marijuana by governments. However, side effects associated with inappropriate use of medical marijuana, accessibility issues and high price associated with medical marijuana, and stringent regulations may hamper the growth of the medical marijuana industry over the forecast period.

Global Medical Marijuana Market: Overview

Increase production and availability of medical marijuana by governments
The increasing demand for marijuana from dispensaries and patients for medical applications is encouraging marijuana growers and government organizations to improve access to legal marijuana for medical research. This is encouraging various governments such as the US government to issue plans to legalize the production of marijuana and expand the number of entities that are certified to grow marijuana plants. This will allow users to place orders for medical marijuana products. Thus, the plans to increase the production and availability of medical marijuana by governments will lead to the expansion of the global medical marijuana market at a CAGR of over 24% during the forecast period.

Increase in funding for research and production of medical marijuana
The legalization of medical marijuana in many countries has provided vendors with opportunities to find new medicinal uses of marijuana. Government organizations in many countries are focusing on funding research on medical marijuana. Some of the vendors are also receiving funds for expanding the production of medical marijuana. For instance, the Department of Health in Australia announced funding for research on the use of marijuana to help cancer patients. This development is expected to have a positive impact on the overall market growth.

Competitive Landscape
With the presence of several major players, the global medical marijuana market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading medical marijuana manufacturers, that include Aphria Inc., Aurora Cannabis Inc., Cannabis Sativa Inc., Canopy Growth Corp., Cronos Group Inc., GW Pharmaceuticals Plc, mCig Inc., Medical Marijuana Inc., United Cannabis Corp., and Vivo Cannabis Inc.

Also, the medical marijuana market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aphria Inc.
  • Aurora Cannabis Inc.
  • Cannabis Sativa Inc.
  • Canopy Growth Corp.
  • Cronos Group Inc.
  • GW Pharmaceuticals Plc
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2019
  • Market outlook
  • Market size and forecast 2019-2024
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
  • Market segmentation by application
  • Comparison by application
  • Chronic pain - Market size and forecast 2019-2024
  • Nausea - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by application
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Increasing number of awareness campaigns
  • Launch of medical marijuana education programs
  • Increase in funding for research and production of medical marijuana
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Aphria Inc.
  • Aurora Cannabis Inc.
  • Cannabis Sativa Inc.
  • Canopy Growth Corp.
  • Cronos Group Inc.
  • GW Pharmaceuticals Plc
  • mCig Inc.
  • Medical Marijuana Inc.
  • United Cannabis Corp.
  • Vivo Cannabis Inc.
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Global tobacco market
Exhibit 02: Segments of global tobacco market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Application - Market share 2019-2024 (%)
Exhibit 19: Comparison by application
Exhibit 20: Chronic pain - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Chronic pain - Year-over-year growth 2020-2024 (%)
Exhibit 22: Nausea - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Nausea - Year-over-year growth 2020-2024 (%)
Exhibit 24: Others - Market size and forecast 2019-2024 ($ millions)
Exhibit 25: Others - Year-over-year growth 2020-2024 (%)
Exhibit 26: Market opportunity by application
Exhibit 27: Customer landscape
Exhibit 28: Market share by geography 2019-2024 (%)
Exhibit 29: Geographic comparison
Exhibit 30: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: North America - Year-over-year growth 2020-2024 (%)
Exhibit 32: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 34: APAC - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: APAC - Year-over-year growth 2020-2024 (%)
Exhibit 36: South America - Market size and forecast 2019-2024 ($ millions)
Exhibit 37: South America - Year-over-year growth 2020-2024 (%)
Exhibit 38: MEA - Market size and forecast 2019-2024 ($ millions)
Exhibit 39: MEA - Year-over-year growth 2020-2024 (%)
Exhibit 40: Key leading countries
Exhibit 41: Market opportunity
Exhibit 42: Impact of drivers and challenges
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Aphria Inc. - Vendor overview
Exhibit 49: Aphria Inc. - Business segments
Exhibit 50: Aphria Inc. - Organizational developments
Exhibit 51: Aphria Inc. - Geographic focus
Exhibit 52: Aphria Inc. - Segment focus
Exhibit 53: Aphria Inc. - Key offerings
Exhibit 54: Aurora Cannabis Inc. - Vendor overview
Exhibit 55: Aurora Cannabis Inc. - Business segments
Exhibit 56: Aurora Cannabis Inc. - Organizational developments
Exhibit 57: Aurora Cannabis Inc. - Geographic focus
Exhibit 58: Aurora Cannabis Inc. - Segment focus
Exhibit 59: Aurora Cannabis Inc. - Key offerings
Exhibit 60: Cannabis Sativa Inc. - Vendor overview
Exhibit 61: Cannabis Sativa Inc. - Business segments
Exhibit 62: Cannabis Sativa Inc. - Organizational developments
Exhibit 63: Cannabis Sativa Inc. - Key offerings
Exhibit 64: Canopy Growth Corp. - Vendor overview
Exhibit 65: Canopy Growth Corp. - Business segments
Exhibit 66: Canopy Growth Corp. - Organizational developments
Exhibit 67: Canopy Growth Corp. - Key offerings
Exhibit 68: Cronos Group Inc. - Vendor overview
Exhibit 69: Cronos Group Inc. - Business segments
Exhibit 70: Cronos Group Inc. - Organizational developments
Exhibit 71: Cronos Group Inc. - Key offerings
Exhibit 72: GW Pharmaceuticals Plc - Vendor overview
Exhibit 73: GW Pharmaceuticals Plc - Business segments
Exhibit 74: GW Pharmaceuticals Plc - Organizational developments
Exhibit 75: GW Pharmaceuticals Plc - Segment focus
Exhibit 76: GW Pharmaceuticals Plc - Key offerings
Exhibit 77: mCig Inc. - Vendor overview
Exhibit 78: mCig Inc. - Business segments
Exhibit 79: mCig Inc. - Organizational developments
Exhibit 80: mCig Inc. - Segment focus
Exhibit 81: mCig Inc. - Key offerings
Exhibit 82: Medical Marijuana Inc. - Vendor overview
Exhibit 83: Medical Marijuana Inc. - Business segments
Exhibit 84: Medical Marijuana Inc. - Organizational developments
Exhibit 85: Medical Marijuana Inc. - Segment focus
Exhibit 86: Medical Marijuana Inc. - Key offerings
Exhibit 87: United Cannabis Corp. - Vendor overview
Exhibit 88: United Cannabis Corp. - Business segments
Exhibit 89: United Cannabis Corp. - Key offerings
Exhibit 90: Vivo Cannabis Inc. - Vendor overview
Exhibit 91: Vivo Cannabis Inc. - Business segments
Exhibit 92: Vivo Cannabis Inc. - Organizational developments
Exhibit 93: Vivo Cannabis Inc. - Geographic focus
Exhibit 94: Vivo Cannabis Inc. - Segment focus
Exhibit 95: Vivo Cannabis Inc. - Key offerings
Exhibit 96: Validation techniques employed for market sizing
Exhibit 97: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Aphria Inc.
  • Aurora Cannabis Inc.
  • Cannabis Sativa Inc.
  • Canopy Growth Corp.
  • Cronos Group Inc.
  • GW Pharmaceuticals Plc
  • MORE
The following companies as the key players in the global medical marijuana market: Aphria Inc., Aurora Cannabis Inc., Cannabis Sativa Inc., Canopy Growth Corp., Cronos Group Inc., GW Pharmaceuticals Plc, mCig Inc., Medical Marijuana Inc., United Cannabis Corp., and Vivo Cannabis Inc.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the increase in funding for research and production of medical marijuana.”

According to the report, one of the major drivers for this market is the plans to increase the production and availability of medical marijuana by governments.

Further, the report states that one of the major factors hindering the growth of this market is the side effects associated with the inappropriate use of medical marijuana.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Aphria Inc.
  • Aurora Cannabis Inc.
  • Cannabis Sativa Inc.
  • Canopy Growth Corp.
  • Cronos Group Inc.
  • GW Pharmaceuticals Plc
  • mCig Inc.
  • Medical Marijuana Inc.
  • United Cannabis Corp.
  • Vivo Cannabis Inc.
Note: Product cover images may vary from those shown
Adroll
adroll